EN
TR
The future of treatment for chondral and osteochondral lesions
Abstract
The population of patients with symptomatic focal or generalized cartilage lesions is growing due to prolongation of life expectancy and to increasing frequency of sports injuries. Cartilage tissue lesions which were defined as untreatable in the past have now become treatable thanks to advances in basic scientific research. With the development of technologies regarding biomaterial, cell and local regulators, and with the introduction of new surgical techniques, it is estimated that, in the near future, clinical applications of cartilage tissue engineering will also receive particular attention in our country. Currently, all alternatives used in the treatment of cartilage lesions have merits and demerits, including arthroscopic debridement and lavage, mesenchymal stem cell stimulation, osteochondral replacement techniques, and autologous chondrocyte transplantation. Preliminary results of experimental cartilage tissue engineering are encouraging for the replacement of disrupted tissue with that having mechanical properties of hyaline cartilage. Clinical applications of cartilage tissue engineering include bioabsorbable scaffolds as extracellular collagen, hyaluronic acid matrices, and genetically engineered bioactive materials.
Keywords
Details
Primary Language
English
Subjects
-
Journal Section
-
Publication Date
December 6, 2007
Submission Date
May 10, 2014
Acceptance Date
-
Published in Issue
Year 2007 Volume: 41 Number: 0
APA
Cirpar, M., & Korkusuz, F. (2007). The future of treatment for chondral and osteochondral lesions. Acta Orthopaedica et Traumatologica Turcica, 41, 153-159. https://doi.org/10.3944/aott.v41i0.2707
AMA
1.Cirpar M, Korkusuz F. The future of treatment for chondral and osteochondral lesions. Acta Orthopaedica et Traumatologica Turcica. 2007;41:153-159. doi:10.3944/aott.v41i0.2707
Chicago
Cirpar, Meric, and Feza Korkusuz. 2007. “The Future of Treatment for Chondral and Osteochondral Lesions”. Acta Orthopaedica et Traumatologica Turcica 41 (December): 153-59. https://doi.org/10.3944/aott.v41i0.2707.
EndNote
Cirpar M, Korkusuz F (December 1, 2007) The future of treatment for chondral and osteochondral lesions. Acta Orthopaedica et Traumatologica Turcica 41 153–159.
IEEE
[1]M. Cirpar and F. Korkusuz, “The future of treatment for chondral and osteochondral lesions”, Acta Orthopaedica et Traumatologica Turcica, vol. 41, pp. 153–159, Dec. 2007, doi: 10.3944/aott.v41i0.2707.
ISNAD
Cirpar, Meric - Korkusuz, Feza. “The Future of Treatment for Chondral and Osteochondral Lesions”. Acta Orthopaedica et Traumatologica Turcica 41 (December 1, 2007): 153-159. https://doi.org/10.3944/aott.v41i0.2707.
JAMA
1.Cirpar M, Korkusuz F. The future of treatment for chondral and osteochondral lesions. Acta Orthopaedica et Traumatologica Turcica. 2007;41:153–159.
MLA
Cirpar, Meric, and Feza Korkusuz. “The Future of Treatment for Chondral and Osteochondral Lesions”. Acta Orthopaedica et Traumatologica Turcica, vol. 41, Dec. 2007, pp. 153-9, doi:10.3944/aott.v41i0.2707.
Vancouver
1.Meric Cirpar, Feza Korkusuz. The future of treatment for chondral and osteochondral lesions. Acta Orthopaedica et Traumatologica Turcica. 2007 Dec. 1;41:153-9. doi:10.3944/aott.v41i0.2707